You need to enable JavaScript to run this app.
The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated
Cookie Policy
Yes, I accept cookies
Steering Committee
About Us
Newsletter
Contact
Visit:
Steering Committee
About Us
Newsletter
Contact
Types
Therapeutics
Congresses
Trials
Expert Opinions
ASH 2020
GvHD Types
Chronic graft-versus-host disease
Acute graft-versus-host disease
Graft-versus-host disease
View all Types
Emily Smith
Emily Smith
Types
Acute graft-versus-host disease
Chronic graft-versus-host disease
Cutaneous aGvHD
Cutaneous cGvHD
GI aGvHD
Graft-versus-host disease
Late acute GvHD
Ocular cGvHD
Pulmonary aGvHD
Pulmonary cGvHD
Steroid-refractory GvHD
Upper GI cGvHD
Interventions
Abatacept
Alemtuzumab
Allo-CBT
Allo-HSCT
Antithymocyte globulin
Auto-HSCT
Basiliximab
Begelomab
Bortezomib
Calcineurin inhibitors
Cellular therapy
Cyclophosphamide
Cyclosporin A
Daclizumab
F-652
Fecal microbiota transplant
Fludarabine
Ibrutinib
Methotrexate
Microbiota therapy
Mycophenolate mofetil
Prednisone
Ruxolitinib
Sirolimus
Tacrolimus
Tocilizumab
Vedolizumab
α1-Antitrypsin
Congresses
ASH 2018
ASH 2019
ASTCT and CIBMTR TCT Meeting 2019
ASTCT and CIBMTR TCT Meeting 2020
EBMT 2019
EHA 2019
Trials
ABLE-cGVHD
BMT CTN 1203
BMT CTN 1501
NCT02406651
All
|
27 Articles
|
6 Videos
|
0 Podcasts